Investors
Subsidiary Pages
Avantrasara offers an opportunity for investment in a start-up with some significant advantages:
High Value/High Growth Market
- In the USA health-care amounts to 16% of GDP and 30% of venture capital investment, and is growing
- Similar levels of spend apply to Europe – growth rates may be faster than the USA
- Combined the two provide a market approaching 1 billion people
- Common focus on driving more value from health care spend
Low Risk
- The high risk element of the research has already been covered, funded by the EU under FP7
- By January 2010 we’ll have proof of our ability to predict hypotension
- Investment is only required to fund the transition from developed and proven technology into something which can be sold
- Time to revenue and positive cash flow is short – less than two years
- Total investment required is low – €2.5 million euros
- Marketing/distribution strategy includes partnering with established market leaders
Market Awareness/Adoption
- The research is directed by leading clinicians – surgeons, intensivists, physicists to solve a problem they all recognize
- Pilot implementations with measurable results are funded by the research in clinical trials
- EU requires the project to inform the market through conferences, papers etc. during the research
- EU will promote adoption of the technology in member states
Value Add
- Aggregation and analysis of international, multi center patient care data to promote best practice
- The infrastructure enables (not challenges) the established process for research, peer review and publication of clinical discoveries
- Spin off opportunities to apply the technology to other conditions and remote monitoring applications
Key Details
- Improved outcomes for 1 – 5 miilion patients per year.
- Reductions in European healthcare costs up to € 5 billion/year.
- Innovation in health care based on prediction of upcoming events.
- Revenues of more than €500 million by 2015.
- Profits of more €300 million by 2015.
- Exit in 2016 through €250 million trade sale.
- Funding requirement for start up € 2.5 million.
For more details and confidential discussions please contact steve.reeves@avantrasara.com or call +44-7810-541601
